A number of investigators have demonstrated that proinflammatory mediators such as interleukin 1β (IL-1β) initiate fibrosis [4], extracellular matrix degradation, and apoptosis [5], eventually leading to tendinopathy. This evidence concerns the gene IL1B and disease of the tendon.